Concepedia

Publication | Closed Access

Intravesical Instillation of c-MYC Inhibitor KSI-3716 Suppresses Orthotopic Bladder Tumor Growth

54

Citations

20

References

2013

Year

Abstract

The c-MYC inhibitor KSI-3716 could be developed as an effective intravesical chemotherapy agent for bladder cancer.

References

YearCitations

Page 1